samedan logo
 
 
spacer
home > news
INDUSTRY NEWS AND PRESS RELEASES
 

Domainex and Pharmidex Announce Drug Discovery Services Alliance

Domainex Ltd and Pharmidex announced today the formation of a strategic alliance, combining their expertise and innovative technologies to provide the market with an integrated, high-quality drug discovery services platform. The joint service offering will amalgamate Domainex’s LeadBuilder technology for cost-effective hit-finding, as well as its highly-experienced medicinal chemistry team, with Pharmidex’s renowned expertise and in vitro and in vivo capabilities in drug metabolism and pharmacokinetics (DMPK). More>>

 
 

Science Transformed into Art

Stunning high-definition images of the inner working of cells

GE Healthcare announced the winners of this year’s IN Cell Image Competition at the High Content Analysis (HCA) Conference in San Francisco, USA. Each of the three regional winners, from Asia, Europe and North America, has won a trip to New York City in March 2010 to see their images shown on NBC’s high-definition TV screen in Times Square. All short-listed images can be viewed at www.gelifesciences.com/incellcompetition. More>>

 
 

Scarab Genomics: White Glove IS Detection Kit

Scarab Genomics introduces its NEW White Glove IS Detection Kit for detecting transposable insertion sequence elements

Scarab Genomics has now launched the White Glove IS Detection Kit to test for the presence of transposable insertion sequence (IS) elements in a DNA of interest. The White Glove IS Detection Kit can be used to detect the presence of IS elements in the genomes of commonly used E coli strains and can also be used to determine which elements have transposed from these genomes into a plasmid of interest propagated in these strains. More>>

 
+1 888 513 7075
info@scarabgenomics.com
www.scarabgenomics.com
1202 Ann Street, Madison, WI, 53713, US
 

Drug Discovery Best Practices for Chief Scientific Officers

Malcolm Weir, a speaker at the marcus evans Discovery Summit 2010 addresses some of the challenges facing drug discovery Chief Scientific Officers across Europe.

Statistics seem almost stacked against developing a fitting drug for a target disease. Drug discovery is plagued by time consuming and costly processes, with extremely high failure rates. Improving some of the underlying processes strangling and stalling the drug discovery process has thus become a top priority for the industry. A speaker at the marcus evans Discovery Summit 2010 taking place in France, 22-24 March, Malcolm Weir, Founder and CEO of Heptares Therapeutics, shares his thoughts on the solutions to some of the issues troubling drug discovery scientists, the latest trends and building alliances. More>>

 
+357 22 849 378
kirstenh@marcusevanscy.com
www.marcusevans.com
PO Box 24797, CY-1304 Nicosia, Cyprus
 

Brecon Strengthens Board Line-Up

Peter Belden Appointed as Managing Director

Brecon Pharmaceuticals, the leading supplier of commercial packaging and clinical trials supplies services for the pharmaceutical and healthcare sectors, has announced the appointment of Peter Belden as managing director. More>>

 
+44 (0)1497 820829
info@breconpharm.com
www.breconpharm.com
Wye Valley Business Park, Hay-on-Wye, Hereford HR3 5PG
 

Catalent Plant Achieves ISO 15378 Certification

Catalent Printed Components Plant in Dublin is the First Secondary Packaging Facility in Ireland to achieve ISO 15378 Certification

Catalent Pharma Solutions, one of the leading providers of advanced technologies and outsourced services to the global pharmaceutical, biotechnology and consumer health industry, announces the recent achievement of ISO 15378 certification of its Printed Components facility in Dublin, Ireland. Catalent is the first secondary packaging company in Ireland to achieve the ISO 15378 certification standard. More>>

 
+1 866 720 3148
sales@catalent.com
www.catalent.com
14 Schoolhouse Road, Somerset NJ 08873, USA
 

Almac Doubles Capacity at North Carolina Facility

The Almac Group has completed a 67,000 square foot expansion to their North Carolina facility in Durham

The Almac Group has completed a 67,000 square foot expansion to their North Carolina facility in Durham, which now houses both the Clinical Services and Diagnostics Divisions. Almac Clinical Services first began occupancy of the additional building on the campus in February 2008 and have since added a 30,000 square foot warehouse complete with two new loading docks. Staff from Almac Diagnostics’ nearby facility in Durham have relocated to the site and are engaged in research activity across a wide-range of projects. More>>

 
+44 (0) 28 3833 2200
info@almacgroup.com
www.almacgroup.com
Almac Group, Almac House, 20 Seagoe Industrial Estate, Craigavon, County Armagh, Northern Ireland, BT63 5QD
 

American Airlines Cargo Unveils ExpediteTC, Solution for Temperature-Controlled Shipments

American Airlines Cargo Division (AA Cargo) today announced the launch of its express temperature-controlled service – ExpediteTCSM. The airline is now offering ExpediteTC to its customers worldwide, following a highly successful trial in the early summer across 10 international origin and destination city pairs. More>>

 
+1 800 227 4622
hdq.cargosales@aa.com
www.aacargo.com
Fort Worth, Texas
 
 
spacer

News and Press Releases

American Airlines Cargo Unveils ExpediteTC, Solution for Temperature-Controlled Shipments

American Airlines Cargo Division (AA Cargo) today announced the launch of its express temperature-controlled service – ExpediteTCSM. The airline is now offering ExpediteTC to its customers worldwide, following a highly successful trial in the early summer across 10 international origin and destination city pairs.
More info >>

Industry Events

Improving Solubility

21-23 June 2010, London, UK

Consequently, Pharma IQ’s 6th Annual Improving Solubility conference taking place in London on 22nd- 23rd June with pre-conference workshops on 21st June will explore the newest solubility enhancement technologies, and the best practice strategies of their implementation to ensure efficiency from discovery to preclinical development.
More info >>

 
©2000-2007 Samedan Ltd.
About Us | Register | Login | Site Map | Terms and Conditions | Contact Us |
Add to favourites

Print this page

Send to a friend
Privacy statement